Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
STIP1 homology and U-box containing protein 1 | 0.544 | 0.692 | 1.9E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
acyl-CoA thioesterase 7 | 0.531 | 0.769 | 0.76 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
antizyme inhibitor 2 | 0.499 | 0.808 | 8.9E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
Myb like, SWIRM and MPN domains 1 | 0.700 | 0.462 | 4.3E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
collagen type VI alpha 3 chain | 0.563 | 0.769 | 1.8E-20 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
colony stimulating factor 2 receptor subunit alpha | 0.670 | 0.615 | 2.4E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2020 | 2020 | ||||||||
|
chymotrypsinogen B1 | 0.760 | 0.385 | 2.4E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
eukaryotic translation elongation factor 2 | 0.599 | 0.731 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
fructose-bisphosphatase 1 | 0.575 | 0.692 | 7.9E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
folate receptor alpha | 0.522 | 0.885 | 0.13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
folate receptor beta | 0.559 | 0.654 | 5.5E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
heparan sulfate 6-O-sulfotransferase 3 | 0.792 | 0.423 | 0.99 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
HECT domain E3 ubiquitin protein ligase 4 | 0.700 | 0.462 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2016 | 2016 | ||||||||
|
RRAD and GEM like GTPase 1 | 0.531 | 0.885 | 5.3E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
G protein-coupled receptor 132 | 0.722 | 0.462 | 1.7E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
glutamate decarboxylase like 1 | 0.497 | 0.808 | 1.4E-21 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
insulin receptor related receptor | 0.508 | 0.808 | 5.4E-24 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 6 | 0.615 | 0.692 | 0.54 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1995 | 1995 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 9 | 0.821 | 0.231 | 0.30 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
cytochrome c oxidase subunit I | 0.441 | 0.885 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
ornithine aminotransferase | 0.593 | 0.731 | 7.7E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
orosomucoid 1 | 0.608 | 0.731 | 1.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
phosphodiesterase 4D | 0.519 | 0.846 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 7 | 0.582 | 0.500 | 6.6E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 |